Gregory Max Landes

7935796, May 3, 2011

Dec 6, 2007

12/001012

Gregory Landes - San Mateo CA, US
Seokjoo Hong - The Woodlands TX, US
Urvi Desai - The Woodlands TX, US
David Powell - Houston TX, US
Xiao Feng - The Woodlands TX, US

Lexicon Pharmaceuticals, Inc. - The Woodlands TX

C07K 16/26
C07K 16/00
C07K 16/46

53038824, 5303871, 5303879, 5303881, 53038815, 5303872

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

8362211, Jan 29, 2013

Dec 30, 2011

13/341860

Kathleen Ann Elias - San Francisco CA, US
Gregory Landes - San Bruno CA, US
Shweta Singh - South San Francisco CA, US
Wouter Korver - South San Francisco CA, US
Andrew Walling Drake - South San Francisco CA, US
Mary Haak-Frendscho - San Francisco CA, US
Gyorgy Pal Snell - San Francisco CA, US
Vinay Bhaskar - San Francisco CA, US

Takeda Pharmaceutical Company Limited - Osaka

C07K 16/18
C07K 16/28
C07K 16/40
C12P 21/08

5303871, 5303873, 53038822, 53038826, 4241301, 4241331, 4241411, 4241431

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

20050131219, Jun 16, 2005

Aug 18, 2004

10/921380

Michael Urdea - Alamo CA, US
Gregory Landes - Livermore CA, US
Gregory Went - Mill Valley CA, US

C12Q001/68
A23J001/00
C07K001/00
C07K014/00
C07K016/00
C07K017/00

530413000

The present invention relates generally to methods for reducing the complexity of a sample. More specifically, the present invention relates to proteomics, the measurement of the protein levels in biological samples, and analysis of proteins in a sample using antibodies that recognize small epitopes.

20070042431, Feb 22, 2007

Oct 23, 2006

11/585507

Michael Urdea - Alamo CA, US
Gregory Landes - Livermore CA, US
Gregory Went - Mill Valley CA, US

Tethys Bioscience, Inc. - Alamo CA

G01N 33/53
C07K 16/40

435007100, 530388260

The present invention relates generally to methods for reducing the complexity of a sample. More specifically, the present invention relates to proteomics, the measurement of the protein levels in biological samples, and analysis of proteins in a sample using antibodies that recognize small epitopes.

20080241934, Oct 2, 2008

Aug 7, 2007

11/890884

Michael S. Urdea - Alamo CA, US
Gregory M. Landes - Livermore CA, US
Gregory T. Went - Mill Valley CA, US

G01N 31/00
G01N 33/00
C12Q 1/00

436 8, 436 86, 435 4

The present invention relates generally to methods for reducing the complexity of a sample. More specifically, the present invention relates to proteomics, the measurement of the protein levels in biological samples, and analysis of proteins in a sample using antibodies that recognize small epitopes.

20110243948, Oct 6, 2011

Mar 28, 2011

13/073617

Gregory Landes - San Bruno CA, US
Seokjoo Hong - Kilgore TX, US
Urvi Desai - The Woodlands TX, US
David Powell - Houston TX, US
Xiao Feng - The Woodlands TX, US

LEXICON PHARMACEUTICALS, INC. - The Woodlands TX

A61K 39/395
C07K 16/18
A61P 3/10
A61P 3/06
A61P 9/10
A61P 3/00
A61P 3/04

4241391, 5303879, 5303873

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

20130171154, Jul 4, 2013

Dec 19, 2012

13/720837

Takeda Pharmaceutical Company Limited - Osaka-shi, JP
Gregory Landes - San Bruno CA, US
Shewta Singh - South San Francisco CA, US
Wouter Korver - South San Francisco CA, US
Andrew Walling Drake - South San Francisco CA, US
Mary Haak-Frendscho - San Francisco CA, US
Gyorgy Pal Snell - San Francisco CA, US
Vinay Bhaskar - South San Francisco CA, US

Takeda Pharmaceutical Company Limited - Osaka-shi

C07K 16/40
C12N 9/99

4241391, 435184

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

20230037373, Feb 9, 2023

Aug 31, 2022

17/823905

- Osaka, JP
Gregory Landes - San Bruno CA, US
Shweta Singh - South San Francisco CA, US
Wouter Korver - South San Francisco CA, US
Andrew Walling Drake - South San Francisco CA, US
Mary Haak-Frendscho - San Francisco CA, US
Gyorgy Pal Snell - South San Francisco CA, US
Vinay Bhaskar - South San Francisco CA, US

C07K 16/40
A61K 47/68
C07K 16/28
C12N 9/99

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.